Luteolin exerts dual anti-NPC effects: G1-phase cell cycle arrest via Akt/GSK-3β/cyclin D1 axis (37) and EBV lytic gene suppression (30). The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.